Inventor profile of:

Ron SCHLINGER

City:

Tel Aviv

Country:

Israel

Published Applications:

19

Last publication date:

2023-12-28

Top Assignees for applications by Ron SCHLINGER

The entities that hold a legal rights for patent applications filed by inventor SCHLINGER Ron:

Recent patent applications by SCHLINGER Ron

Ron SCHLINGER from Tel Aviv, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-12-28
US20230414537A1
Human necessities

TOPICAL NAFTIFINE COMPOSITIONS

#2 | 2023-09-21
US20230293543A1
Human necessities

FENOLDOPAM TOPICAL FORMULATIONS FOR TREATING SKIN DISORDERS

#3 | 2023-08-10
US20230248641A1
Human necessities

TOPICAL MONTELUKAST FOR TREATMENT OF ATOPIC DERMATITIS

#4 | 2023-02-23
US20230059107A1
Human necessities

STABLE TOPICAL COMPOSITIONS OF FENOLDOPAM

#5 | 2023-02-23
US20230057282A1
Human necessities

COMPOSITIONS COMPRISING DESOXIMETASONE AND TAZAROTENE

#6 | 2022-02-10
US20220040089A1
Human necessities

Stable topical compositions of fenoldopam

#7 | 2022-01-20
US20220016028A1
Human necessities

Topical Montelukast formulations

#8 | 2021-12-23
US20210393613A1
Human necessities

Topical Montelukast formulations

#9 | 2021-08-05
US20210236423A1
Human necessities

Topical Montelukast formulations

#10 | 2021-01-14
US20210009751A1
Chemistry; metallurgy

Alternating and semi-alternating poly(ester-anhydride) copolymers

#11 | 2020-07-30
US20200237651A1
Human necessities

TOPICAL MONTELUKAST FOR TREATMENT OF ATOPIC DERMATITIS

#12 | 2020-04-02
US20200101163A1
Human necessities

Compositions comprising biodegradable copolymers for prolonged local release of an antibiotic

#13 | 2020-02-04
US15585689
Human necessities

Topical montelukast for treatment of atopic dermatitis

#14 | 2019-10-31
US20190328746A1
Human necessities

Fenoldopam topical formulations for treating skin disorders

#15 | 2019-05-02
US20190125792A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING FERRIC CITRATE AND METHODS FOR THE PRODUCTION THEREOF

#16 | 2018-02-15
US20180043026A1
Human necessities

Alternating and semi-alternating poly(ester-anhydride) copolymers

#17 | 2017-04-20
US20170106018A1
Human necessities

Pharmaceutical compositions comprising ferric citrate and methods for the production thereof

#18 | 2011-03-03
US20110052648A1
Human necessities

ORAL MODIFIED-RELEASE FORMULATIONS CONTAINING THIAZEPINES

#19 | 2010-11-04
US20100278909A1
Human necessities

PROCESS FOR FORMING SOLID ORAL DOSAGE FORMS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS

InventorID:

1850773 ⎘